Hemophagocytic Lymphohistiocytosis and Pancreatic Cancer: A Rare Association

被引:0
作者
Jaan, Ali [1 ]
Khalid, Farhan [2 ]
Ahmed, Abdullah M. Firoze [1 ]
Salman, Ahmed [3 ]
Meghal, Trisha [4 ]
Du, Doantrang [2 ]
机构
[1] Rochester Gen Hosp, Dept Internal Med, Rochester, NY USA
[2] Monmouth Med Ctr, Dept Internal Med, Long Branch, NJ 07740 USA
[3] Rochester Gen Hosp, Dept Hematol Oncol, Rochester, NY USA
[4] Monmouth Med Ctr, Dept Hematol Oncol, Long Branch, NJ USA
关键词
HLH; Pancreatic cancer; Internal medicine; Immunology; Hematology; ADULT;
D O I
10.55729/2000-9666.1225
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A marrow biopsy couldn't be pursued as the patient died within a week of hospitalization. An autopsy was not per-formed as per family's request. Conclusion: HLH can occur secondary to solid cell malignancies including those from the pancreas and should be kept high in the differential in critically ill cancer patients who are nonresponsive to antibiotics. H-score has been reported to be a more sensitive tool compared to the HLH protocol, especially if used earlier during the presentation. Further research is needed to compare diagnostic efficacy for HLH protocol verses H-score especially in critically ill patients as they might benefit from steroid trial. A marrow biopsy couldn't be pursued as the patient died within a week of hospitalization. An autopsy was not per-formed as per family's request.Conclusion: HLH can occur secondary to solid cell malignancies including those from the pancreas and should be kept high in the differential in critically ill cancer patients who are nonresponsive to antibiotics. H-score has been reported to be a more sensitive tool compared to the HLH protocol, especially if used earlier during the presentation. Further research is needed to compare diagnostic efficacy for HLH protocol verses H-score especially in critically ill patients as they might benefit from steroid trial.
引用
收藏
页码:68 / 71
页数:6
相关论文
共 19 条
[1]   Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study [J].
Bergsten, Elisabet ;
Horne, AnnaCarin ;
Arico, Maurizio ;
Astigarraga, Itziar ;
Egeler, R. Maarten ;
Filipovich, Alexandra H. ;
Ishii, Eiichi ;
Janka, Gritta ;
Ladisch, Stephan ;
Lehmberg, Kai ;
McClain, Kenneth L. ;
Minkov, Milen ;
Montgomery, Scott ;
Nanduri, Vasanta ;
Rosso, Diego ;
Henter, Jan-Inge .
BLOOD, 2017, 130 (25) :2728-2738
[2]   Secondary hemophagocytic lymphohistiocytosis and severe sepsis/systemic inflammatory response syndrome/multiorgan dysfunction syndrome/macrophage activation syndrome share common intermediate phenotypes on a spectrum of inflammation [J].
Castillo, Leticia ;
Carcillo, Joseph .
PEDIATRIC CRITICAL CARE MEDICINE, 2009, 10 (03) :387-392
[3]  
Debaugnies F, 2016, AM J CLIN PATHOL, V145, P862, DOI [10.1093/AJCP/AQW076, 10.1093/ajcp/aqw076]
[4]  
Emile JF, 2016, BLOOD, V127, P2672, DOI [10.1182/blood-2016-01690636, 10.1182/blood-2016-01-690636]
[5]   A Web-Based Delphi Study for Eliciting Helpful Criteria in the Positive Diagnosis of Hemophagocytic Syndrome in Adult Patients [J].
Hejblum, Gilles ;
Lambotte, Olivier ;
Galicier, Lionel ;
Coppo, Paul ;
Marzac, Christophe ;
Aumont, Cedric ;
Fardet, Laurence .
PLOS ONE, 2014, 9 (04)
[6]   HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis [J].
Henter, Jan-Inge ;
Horne, AnnaCarin ;
Arico, Maurizio ;
Egeler, R. Maarten ;
Filipovich, Alexandra H. ;
Imashuku, Shinsaku ;
Ladisch, Stephan ;
McClain, Ken ;
Webb, David ;
Winiarski, Jacek ;
Janka, Gritta .
PEDIATRIC BLOOD & CANCER, 2007, 48 (02) :124-131
[7]   INCIDENCE IN SWEDEN AND CLINICAL-FEATURES OF FAMILIAL HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS [J].
HENTER, JI ;
ELINDER, G ;
SODER, O ;
OST, A .
ACTA PAEDIATRICA SCANDINAVICA, 1991, 80 (04) :428-435
[8]   HYPERCYTOKINEMIA IN FAMILIAL HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS [J].
HENTER, JI ;
ELINDER, G ;
SODER, O ;
HANSSON, M ;
ANDERSSON, B ;
ANDERSSON, U .
BLOOD, 1991, 78 (11) :2918-2922
[9]  
HERNANDEZNIETO L, 1977, LANCET, V1, P261
[10]  
Hines M., 2019, CRITICAL CARE PEDIAT, P159, DOI [10.1007/978-3-030-01322-6_9, DOI 10.1007/978-3-030-01322-6_9]